Adverse Drug Events Unknown Status Phase 2 Trials for Pazopanib (DB06589)

Also known as: Adverse Drug Event

IndicationStatusPhase
DBCOND0029335 (Adverse Drug Events)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02324803Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC PatientsTreatment